![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 21, 2023 3:52:26 PM
I wonder if Humanigen had a role in the Investigator Initiated CAR-T study of the Gracell platform. And we may also have invested Humanigen funds for the Baudax/TeraImmune acquisition. I suspect investment firms could be queued-up for a private offering. And with the Jefferies and Cantor investor presentations, maybe we will see a controlled equity offering, as well. Shares could become available if the company announces a 5:1 forward stock split, and if we also deplete our open shelf registration for $80M+.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM